NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals Price to Book Value: 0.8647 for April 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 05, 2024 | 0.8647 |
| April 04, 2024 | 0.8647 |
| April 03, 2024 | 0.876 |
| April 02, 2024 | 0.876 |
| April 01, 2024 | 0.876 |
| March 28, 2024 | 0.8928 |
| March 27, 2024 | 0.9097 |
| March 26, 2024 | 0.8703 |
| March 25, 2024 | 0.8703 |
| March 22, 2024 | 0.8703 |
| March 21, 2024 | 0.876 |
| March 20, 2024 | 0.8703 |
| March 19, 2024 | 0.876 |
| March 18, 2024 | 0.876 |
| March 15, 2024 | 0.8816 |
| March 14, 2024 | 0.8591 |
| March 13, 2024 | 0.8591 |
| March 12, 2024 | 0.8647 |
| March 11, 2024 | 0.8647 |
| March 08, 2024 | 0.8591 |
| March 07, 2024 | 0.8591 |
| March 06, 2024 | 0.8535 |
| March 05, 2024 | 0.8591 |
| March 04, 2024 | 0.8535 |
| March 01, 2024 | 0.8535 |
| Date | Value |
|---|---|
| February 29, 2024 | 0.8535 |
| February 28, 2024 | 0.8591 |
| February 27, 2024 | 0.9153 |
| February 26, 2024 | 0.8563 |
| February 23, 2024 | 1.072 |
| February 22, 2024 | 1.072 |
| February 21, 2024 | 1.071 |
| February 20, 2024 | 0.898 |
| February 16, 2024 | 0.8534 |
| February 15, 2024 | 0.8311 |
| February 14, 2024 | 0.8199 |
| February 13, 2024 | 0.8199 |
| February 12, 2024 | 0.8478 |
| February 09, 2024 | 0.8478 |
| February 08, 2024 | 0.7976 |
| February 07, 2024 | 0.7976 |
| February 06, 2024 | 0.792 |
| February 05, 2024 | 0.7753 |
| February 02, 2024 | 0.8032 |
| February 01, 2024 | 0.8311 |
| January 31, 2024 | 0.8534 |
| January 30, 2024 | 0.8646 |
| January 29, 2024 | 0.859 |
| January 26, 2024 | 0.8311 |
| January 25, 2024 | 0.7809 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2924
Minimum
Nov 17 2023
8.744
Maximum
Mar 17 2021
3.234
Average
3.484
Median
Price to Book Value Benchmarks
| Catalent Inc | 2.696 |
| AIM ImmunoTech Inc | 4.487 |
| Perspective Therapeutics Inc | 3.738 |
| Protalix BioTherapeutics Inc | 2.781 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 28.76 |
| Price | 1.54 |
| Earnings Yield | -112.3% |
| Market Cap | 128.53M |